Unknown NA INTERVENTIONAL 2-arm NCT03166683

Standard of Care Versus Hemopatch® During Liver Resection (IBERLIVER)

Standard of Care Versus a New Collagen and Polyethylene Glycol Haemostatic/Sealant Patch (Hemopatch) During Liver Resection. A Multicentre, Non-inferiority Prospective Randomized Study (IBERLIVER-study)

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions Bile Leak Hemorrhage Liver Liver Cancer Surgery Tumor Liver

Interventions Hemopatch Standard of care

Updated 6 times since 2017 Last updated: Nov 8, 2017 Started: Dec 31, 2017 Primary completion: Apr 30, 2020 Completion: Sep 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bile Leak and Hemorrhage Liver and is currently ongoing. Fundación Pública Andaluza para la gestión de la Investigación en Sevilla leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Oct 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Oct 2020 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jun 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Data source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.